The spontaneous release of acetylcholinesterase in rat substantia nigra is altered by local changes in extracellular levels of dopamine

Neurochemistry International

Volumn 29, Issue 6, 1996, Pages 629-635

  Dally, Jonathan J ^a   Schaeffer, Margitta ^b   Greenfield, Susan A ^a  

^a OX1 3QT   (United Kingdom)

^b Inst fur Zool der Tech H   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; DEXAMPHETAMINE; DOPAMINE; POTASSIUM ION; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME LOCALIZATION; ENZYME RELEASE; EXTRACELLULAR SPACE; GUINEA PIG; HISTOLOGY; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ACETYLCHOLINESTERASE; ANIMALS; CHEMILUMINESCENT MEASUREMENTS; DEXTROAMPHETAMINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DRUG EVALUATION, PRECLINICAL; MALE; PIPERAZINES; POTASSIUM; RATS; SPECIES SPECIFICITY; SUBSTANTIA NIGRA;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0030560678     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(96)00057-5     Document Type: Article

References (44)

1. Andersen P.H. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166(3):1989;493-504.
2. Björklund A., Lindvall O. Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res. 83:1978;531-537.
3. Cheramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature. 289:1981;537-542.
4. Chiueh C.C., Markey S.P., Burns R.S., Johannessen J.N., Jacobowitz D.M., Kopin I.J. Neurochemical and behavioural effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rat, guinea-pig and monkey. Psychopharm. Bull. 20(3):1984;548-553.
5. Cuello A.C., Romero E., Smith A.D. In vitro release of acetylcholinesterase from the rat substantia nigra. J. Physiol. 312:1981;14P.
6. Dally J.J., Greenfield S.A. The release of acetylcholinesterase in vivo is regulated by dopaminergic systems in the guinea-pig substantia nigra. Neurochem. Int. 25(4):1994;339-344.
7. Dally J.J., Temlett J.A. and Greenfield S.A. (1996) Differential release of acetylcholinesterase in vivo, from the guinea-pig substantia nigra compared to the caudate putamen following dopamine depletion. Neuropharmacology (in press).
8. Dickie B.G.M., Budd T.C., Vaux D., Greenfield S.A. Uptake of acetylcholinesterase by neurones in the substantia nigra. Eur. J. Neurosci. 7:1995;351-357.
9. Elverfors A., Nissbrandt H. Reserpine-insensitive dopamine release in the substantia nigra. Brain Res. 557:1991;5-12.
10. Glick S.D., Crane L.A. Function of nigral dopamine receptors. Brain Res. 156(2):1978;380-381.
11. Greenfield S.A. A noncholinergic action of acetylcholinesterase (AChE) in the brain: from neuronal secretion to the generation of movement. Cell Mol. Neurobiol. 11(1):1991;55-77.
12. Greenfield S.A., Shaw S.G. Release of acetylcholinesterase and aminopeptidase in vivo following infusion of D-amphetamine into the substantia nigra. Neuroscience. 7(11):1982;2883-2893.
13. Greenfield S., Cheramy A., Leviel V., Glowinski J. In vivo release of acetylcholinesterase in cat substantia nigra and caudate nucleus. Nature. 284(5754):1980;355-357.
14. Greenfield S.A., Grünewald R.A., Foley P., Shaw S.G. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxy-dopamine lesions of the nigrostriatal pathway. J. Comp. Neurol. 214:1983;87-92.
15. Greenfield S.A., Appleyard M.E., Bloomfield M.R. 6-hydroxydopamine-induced turning behaviour in the rat: the significance of acetylcholinesterase in cerebrospinal fluid. Behav. Brain Res. 21:1986;47-54.
16. Greenfield S.A., Jack J.J., Last A.T., French M. An electrophysiological action of acetylcholinesterase independent of its catalytic site. Exp. Brain Res. 70(2):1988;441-444.
17. Greenfield S.A., Nedergaard S., Webb C., French M. Pressure ejection of acetylcholinesterase within the guinea-pig substantia nigra has non-classical actions on the pars compacta cells independent of selective receptor and ion channel blockade. Neuroscience. 29(1):1989;21-25.
18. Hawkins C.A., Greenfield S.A. Non-cholinergic action of exogenous acetylcholinesterase in the rat substantia nigra. I. Differential effects on motor behaviour Behav Brain Res. 48:1992;153-157.
19. Henderson Z., Greenfield S.A. Ultrastructural localization of acetylcholinesterase in substantia nigra: a comparison between rat and guinea pig. J. Comp. Neurol. 230:1984;278-286.
20. Irwin, I. and Langston, J.W. (1993) MPTP and Parkinson's Disease. In Natural and Synthetic Neurotoxins, Harvey A., ed., pp. 225-256. Academic Press, London.
21. Jones S.A., Greenfield S.A. Behavioural correlates of the release and subsequent action of acetylcholinesterase secreted in the substantia nigra. Eur. J. Neurosci. 3:1991;292-295.
22. Jones S.A., Ellis J.R.C., Klegeris A., Greenfield S.A. The relationship between visual stimulation, behaviour and continuous release of protein in the substantia nigra. Brain Res. 560:1991;163-166.
23. Jones S.A., Dickie B.G.M., Klegeris A., Greenfield S.A. The subthalamo-nigral pathway regulates movement and concomitant acetylcholinesterase release from the substantia nigra. J. Neural Transm. Gen. Sect. 98:1994;23-37.
24. Kaakkola S., Teräväinen H. Animal models of Parkinsonism. Pharmacol. Toxicol. 67:1990;95-100.
25. Kapoor R., Webb C., Greenfield S.A. Endogenous dopamine modifies electroresponsiveness of pars compacta cells in the guinea pig substantia nigra in vitro. Exp. Brain Res. 74:1989;653-657.
26. Kelly P.H., Moore K.E. Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, gamma-aminobutyric acid, gamma-hydroxybutyric acid, apomorphine and amphetamine. Neuropharmacology. 17(3):1978;169-174.
27. Last A.T., Greenfield S.A. Neuroleptic-induced changes in the firing pattern of guinea pig nigrostriatal neurons. Exp. Brain Res. 66(2):1987;394-400.
28. Last A.T., Greenfield S.A. Acetylcholinesterase has a non-cholinergic neuromodulatory action in the guinea-pig substantia nigra. Exp. Brain Res. 67(2):1987;445-448.
29. Leviel V., Cheramy A., Glowinski J. Role of the dendritic release of dopamine in the reciprocal control of two nigro-striatal dopaminergic pathways. Nature. 280:1979;236-239.
30. Llinás R., Greenfield S.A., Jahnsen H. Electrophysiology of pars compacta cells in the in vitro substantia nigra - a possible mechanism for dendritic release. Brain Res. 294(1):1984;127-132.
31. 3H]dopamine release from dendrosomes of rat substantia nigra. Naunyn-Schmiedebergs Arch. Pharmacol. 344(3):1991;275-280.
32. Nedergaard S., Hopkins C., Greenfield S.A. Do nigro-striatal neurones possess a discrete dendritic modulatory mechanism? Electrophysiological evidence from the actions of amphetamine in brain slices. Exp Brain Res. 69:1988;444-448.
33. Nedergaard S., Bolam J.P., Greenfield S.A. Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature. 333:1988;174-177.
34. Nissbrandt H., Engberg G., Pileblad E. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra. Naunyn Schmiedebergs Arch Pharmacol. 344(1):1991;16-28.
35. Paxinos, G. and Waston, C. (1982) The Rat Brain in Stereotaxic Co-ordinates. Academic press, New York.
36. Perry T.L., Yong V.W., Ito M., Jones K., Wall R.A., Foulks J.G., Wright J.M., Kish S.J. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea-pig. Life Sci. 36:1985;1233-1238.
37. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Ann. Rev. Pharmacol. Toxicol. 32:1993;639-677.
38. Simon J.R., Ghetti B. Is there a significant somatodendritic uptake of dopamine in the substantia nigra? Evidence from the weaver mutant mouse. Neurochem. Int. 22(5):1993;471-477.
39. Taylor S.J., Greenfield S.A. Release of acetylcholinesterase from the guinea-pig substantia nigra during peripheral nerve stimulation. Brain Res. 482:1989;356-358.
40. Taylor S.J., Haggblad J., Greenfield S.A. Measurement of cholinesterase activity released from the brain "on-line" and in vivo. Neurochem. Int. 15(2):1989;199-205.
41. Taylor S.J., Jones S.A., Haggblad J., Greenfield S.A. "On-line" measurement of acetylcholinesterase release from the substantia nigra of the freely moving guinea-pig. Neuroscience. 37(1):1990;71-76.
42. Ungerstedt U. Post-synaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. 82(387):1971;69-93.
43. Ungerstedt U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. 82(387):1971;95-122.
44. Williams G.V., Millar J. Concentration-dependent actions of stimulated dopamine release from neuronal activity in rat striatum. Neuroscience. 39(1):1990;1-16.